Adhera Therapeutics, Inc. company info

CIK 737207
IRS Number 112658569
State of incorporation DE
Business address 4721 EMPEROR BOULEVARD
SUITE 350
DURHAM
NC
27703
Mail address 4721 EMPEROR BOULEVARD
SUITE 350
DURHAM
NC
27703

Short summary

Adhera Therapeutics, Inc. is a North Carolina company, with head office located at 4721 Emperor Boulevard Durham, North Carolina 27703. In 2018 the company owned a total of 8.30 million USD worth of assets, including 7.45 million USD worth of current assets and 844.31 thousand USD worth of non-current assets. 2010 was the year when the company amassed the most assets.

Adhera Therapeutics, Inc. Income Statement

Name [in Millions USD]200720082009201020112012201320142015201620172018Trends
Revenue, Net 14.732.462.24
Selling, General and Administrative Expense 10.0910.368.375.25
Research and development 14.8818.1111.445.170.720.690.320.110.91
Operating Expenses 25.4331.9937.2312.102.484.021.110.766.09
Operating Income (Loss) -10.69-29.53-35.00-7.88-0.37-3.52-3.99-0.76-6.09
Investment Income, Interest and Dividend 0.010.24
Income Tax Expense (Benefit) 1.140.04-0.040.000.000.00
Net income -8.05-27.75-29.42-9.55-1.57-6.483.34-0.84-6.22

Adhera Therapeutics, Inc. Balance Sheet

Name [in Millions USD]200720082009201020112012201320142015201620172018Trends
Cash and cash equivalents 1.070.100.214.320.730.32
Accounts Receivable, Net, Current 0.210.0100.010.14
Inventories 0.080.36
Property, Plant and Equipment, Gross 11.68
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 8.749.25
Goodwill 3.503.50
Intangible Assets, Net (Excluding Goodwill) 22.736.706.706.706.706.702.732.310.82
Other Assets, Noncurrent 0.000.050.020.050.05
Total assets 7.2332.2010.196.8611.107.557.156.6314.478.30
Current assets 2.666.431.590.164.400.810.450.408.657.45
Non-current assets 6.235.820.84
Accounts payable 2.112.613.541.581.050.501.330.941.130.85
Taxes Payable, Current 0.450.10
Total current liabilities 5.136.916.405.582.022.123.114.162.342.19
Long-term Debt 1.391.20
Deferred income taxes 1.202.352.382.352.352.352.35
Total liabilities 14.1215.8912.0411.0614.4310.056.072.70
Common Stock, Value, Issued 307.94322.09323.340.160.160.180.060.060.06
Retained Earnings (Accumulated Deficit) -112.10-263.02-298.02-323.94-328.37-336.47-336.47-334.03-4.21-14.31-22.47

Adhera Therapeutics, Inc. Cash Flow

Name [in Millions USD]200720082009201020112012201320142015201620172018Trends
Net income -8.05-27.75-29.42-9.55-1.57-6.483.34-0.84-6.22
Amortization of Intangible Assets 0.050.45
Depreciation and amortization 2.371.581.250.56
Deferred Income Tax Expense (Benefit) 1.140.04-0.04
Accounts receivable 0.18-0.15-0.060.01-0.000.50-0.50
Accounts payable 0.641.64-0.670.490.01-0.560.09-0.880.43
Deferred revenue -0.720.030.81-0.73-0.12
Net Cash Provided by (Used in) Operating Activities -7.53-16.80-16.12-0.74-0.52-1.26
Payments to Acquire Property, Plant, and Equipment 0.090.400.00
Payments to Acquire Businesses, Net of Cash Acquired -0.01
Payments to Acquire Intangible Assets 0.38
Net Cash Provided by (Used in) Investing Activities 2.344.640.000.01-0.38
Net Cash Provided by (Used in) Investing Activities, Continuing Operations 0.001.060.41-0.05
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 2.720.03
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 2.720.03
Proceeds from Issuance of Common Stock 10.25
Net Cash Provided by (Used in) Financing Activities 4.8512.4816.0210.361.64
Cash and Cash Equivalents, Period Increase (Decrease) -0.340.32-0.09